Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.
为了降低鼠源抗体引起的超敏反应,治疗性单克隆抗体已
型抗体,人源化抗体发展到全人抗体。
Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.
为了降低鼠源抗体引起的超敏反应,治疗性单克隆抗体已型抗体,人源化抗体发展到全人抗体。
声明：以上
、词性分类
联网资源自动生成，部分未经过人工审核，其表达内容亦不代表本软件的观点；若发现问题，欢迎向我们指正。
